Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · IEX Real-Time Price · USD
0.670
+0.003 (0.37%)
Apr 24, 2024, 9:41 AM EDT - Market open

Quoin Pharmaceuticals Cash Flow Statement

Millions ILS. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Net Income
-8.69-9.38-21.46-2.1-1.56-6.21-8.71-4.73-3.14-1.71
Upgrade
Depreciation & Amortization
0.10.10.10.10.020.140.110.110.020.01
Upgrade
Share-Based Compensation
1.090.760001.41.660.480.410.25
Upgrade
Other Operating Activities
-0.380.0315.640.650.24-2.631.45-0.310.330.1
Upgrade
Operating Cash Flow
-7.86-8.48-5.72-1.34-1.3-7.29-5.48-4.45-2.38-1.36
Upgrade
Capital Expenditures
0-0.25-0.63-0.130-0.2-0.08-0.36-0.08-0.07
Upgrade
Change in Investments
2.19-9.90000.126.03-6.030-3.46
Upgrade
Other Investing Activities
-----4.31-2.830.831.06-
Upgrade
Investing Cash Flow
2.19-10.15-0.63-0.1304.233.11-5.560.98-3.53
Upgrade
Share Issuance / Repurchase
5.8514.8810.1003.944.8810.781.974.47
Upgrade
Debt Issued / Paid
-0.63-0.873.170.8600000-0.17
Upgrade
Other Financing Activities
--0.230.931.3-----
Upgrade
Financing Cash Flow
5.2214.0113.51.791.33.944.8810.781.974.3
Upgrade
Exchange Rate Effect
000000.38-0.21-0.04-0.02-0
Upgrade
Net Cash Flow
-0.46-4.627.160.32-01.262.30.730.55-0.59
Upgrade
Free Cash Flow
-7.86-8.73-6.35-1.46-1.3-7.5-5.57-4.81-2.46-1.43
Upgrade
Free Cash Flow Per Share
-7.97-21.62-0.24-0.07-0.07-3475.58-2982.96-3166.45-1980.52-1299.15
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).